Independent report

Meningococcal B vaccination for the prevention of gonorrhoea, JCVI advice: 10 November

JCVI statement setting out advice on the use of the 4CMenB vaccine for the prevention of gonorrhoea in those who are at increased risk of infection.

• From: Department of Health and Social Care
• Published: 10 November 2023

Documents

JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea

HTML

Details

This statement provides advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the 4-component serogroup B meningococcal (4CMenB) vaccine for the prevention of gonorrhoea in terms of programme cost-effectiveness and likely impact on epidemiology.

Published 10 November 2023